Our Recommendations
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex B. Qualitative and economic evidence reports (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex A. Quantitative evidence reports (2025)
- Mpox Continental Preparedness and Response Plan for Africa (2024)
- Tests diagnostiques pour la détection du virus de la variole simienne (orthopoxvirus simien, ou MPXV) (2024)
New Publications
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex B. Qualitative and economic evidence reports (2025)
- WHO guidelines on meningitis diagnosis, treatment and care. Web Annex A. Quantitative evidence reports (2025)
- WHO guidelines on meningitis diagnosis, treatment and care (2025)
- Infection prevention and control and water sanitation and hygiene in health facilities during mpox disease outbreaks: rapid assessment tool, user guide (2025)
Filter
902
Featured
Recommendations
159
New Publications
241
Language
Document type
No document type
425
Guidelines
133
Training Material
51
Manuals
44
Situation Updates
41
Fact sheets
40
Studies & Reports
38
Online Courses
38
Strategic & Response Plan
30
Infographics
28
Resource Platforms
22
Videos
11
Dashboards/Maps
1
Countries / Regions
Congo, Democratic Republic of
32
Brazil
27
Nigeria
23
Guinea
23
Sierra Leone
21
Africa
21
Liberia
20
Madagascar
20
Latin America and the Carribbean
19
Senegal
18
Burkina Faso
17
Rwanda
16
Global
16
Côte d’Ivoire / Ivory Coast
14
Germany
13
Angola
12
Mozambique
11
Western and Central Europe
11
Russia
11
Mali
11
West and Central Africa
9
India
9
Uganda
8
Indonesia
8
Ghana
7
Syria
7
Ethiopia
7
East and Southern Africa
6
South Africa
6
Somalia
6
Paraguay
5
Portugal
5
Yemen
5
Chad
5
South Sudan
5
Colombia
4
Kenya
4
Togo
4
Burundi
4
Peru
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Argentina
4
Vietnam
4
Sri Lanka
4
China
3
Cameroon
3
Niger
3
Central African Republic
3
Nepal
2
Afghanistan
2
Zimbabwe
2
USA
2
Asia
2
Venezuela
2
Bolivia
2
Bangladesh
2
Serbia
1
Turkey
1
Benin
1
Gambia
1
Iran
1
Kyrgyzstan
1
Philippines
1
Italy
1
Haiti
1
Dominican Republic
1
Guinea-Bissau
1
Croatia
1
Tanzania
1
Saudi Arabia
1
Western Pacific Region
1
Turkmenistan
1
Japan
1
United Kingdom
1
Spain
1
Azerbaijan
1
Bosnia and Herzegovina
1
Sudan
1
Honduras
1
Zambia
1
Ecuador
1
Myanmar / Burma
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Key Resources
149
Clinical Guidelines
147
Countries
105
Public Health
60
Capacity Building
49
Pharmacy & Technologies
33
Women & Child Health
4
The Global Strategic Preparedness and Response Plan (SPRP) for mpox, covering the six-month period from September 2024 to February 2025, provides a framework for public health preparedness and response to the mpox emergency. The current draft, subject to Member State input, outlines the urgent actio...
Pour mieux comprendre les termes de santé publique utilisés dans cette fiche maladie
Flyer German
WHO Director-General Dr Tedros Adhanom Ghebreyesus has determined that the upsurge of mpox in the Democratic Republic of the Congo (DRC) and a growing number of countries in Africa constitutes a public health emergency of international concern (PHEIC) under the International Health Regulations (2005...
The monkeypox virus (MPXV) clade I epidemic that has been affecting the Democratic Republic of the Congo
(DRC) since November 2023 has recently spread to several other African countries including Burundi, Rwanda,
Uganda and Kenya. The size of these outbreaks could be larger than reported due to un...
Tests diagnostiques pour la détection du virus de la variole simienne (orthopoxvirus simien, ou MPXV)
recommended
Orientations provisoires
The Pandemic Influenza Preparedness (PIP) Framework is a World Health Assembly resolution adopted unanimously by all Member States in 2011. It brings together Member States, industry, other stakeholders and WHO to implement a global approach to pandemic influenza preparedness and response. The Frame...
WHO needs US$ 87.4 million over 6 months, from September 2024 to February 2025, to work with countries, partners and other stakeholders to stop and contain the current outbreak of mpox.
Download (419.34 KB)
On 14 August 2024, the Director-General of the World Health Organization (WHO) determined that the resurgence of Mpox in the Democratic Republic of Congo (DRC) and a growing number of countries in Africa constitutes a Public Health Emergency of International Concern (PHEIC). Te...
Bulletin 11 August 2024
Le Directeur général de l’OMS, le Dr Tedros Adhanom Ghebreyesus, a estimé que la recrudescence de variole simienne (mpox) en République démocratique du Congo (RDC) et dans un nombre croissant de pays d’Afrique constituait une urgence de santé publique de portée internationale (USPPI) au t...
Given the circulation of the variant of clade I of mpox virus (MPXV) in the African Region, which is associated in the African Region with sustained transmission and the occurrence of cases in a wider range of age groups, including children, the Pan American Health Organization/World Health Organiza...
On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS). This was followed the next day by the World Health Organization (WHO), which extended the alert internationally as a public ...
Situation Update
En décembre 2022, la République démocratique du Congo a déclaré une flambée nationale de variole simienne. Un système de gestion des incidents est en place depuis février 2023, compte tenu du nombre croissant de cas signalés. Depuis septembre 2023, l’épidémie de variole simienne continu...
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the disease, and reducing spillover of the virus from ani...
i. A person who is a contact of a probable or confirmed mpox case in the 21 days before the onset of signs or symptoms, and who presents with any of the following: acute onset of fever (>38.5°C), headache, myalgia (muscle pain/body aches), back pain, profound weakness or fatigue.
OR
ii. A per...
mise à jour de la situation
